Breast Cancer, Pathology, Ultrasound
Conditions
Brief summary
The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS).
Detailed description
The aim of this study was to investigate the added value of contrast-enhanced ultrasound (CEUS) for differentiating low risk patients with breast nodules categorized as 4A using the Breast Imaging Reporting and Data System (BI-RADS). The study included patients with 4A nodules confirmed by core biopsy and/or surgery. The CEUS parameters were assessed to evaluated the added value in BI-RADS 4A nodules
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
patients with nodules which were sonographically classified as BI-RADS 4 A breast lesion
Exclusion criteria
(i) absence of a pathologic diagnosis; (ii) presence of breast nodules that were too large to compare with normal parenchyma; (iii) patients with radiotherapy and chemotherapy of breast cancer; and (iv) skin disorders.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| CEUS | up to 3 months | if the result of CEUS is positive,the nodule was downgraded. if the result of CEUS is negative, the nodule was kept as BI RADS 4A category. Then all nodules were submitted to biopsy or surgery. |
Countries
China